Recent findings have shown that Ascl1 acts as a pioneering factor that initializes neuronal reprogramming and drives neuronal differentiation of multiple cell types, including reactive astroglia induced by stroke [8] and glioblastoma stem cells [9], thus effectively diminishing CNS damage resulting from their proliferation. The gene discussed is ASCL1; the disease is glioblastoma.